子宫内膜损伤导致的不孕不育,有望迎来新的治疗手段

2022-02-19 南方医科大学珠江医院 网络

一种可重构子宫衍生材料(RUMs)的模型,可有效应对子宫修复难题。专家预计,此项产品3-4年后可应用于临床。

因子宫内膜损伤导致的不孕不育有望迎来新的治疗手段!

日前,南方医科大学珠江医院妇产医学中心博士研究生易笑在珠江医院转化医学中心干细胞与再生医学研究所所长高毅,及珠江医院妇产医学中心主任王沂峰的指导下,提出一种可重构子宫衍生材料(RUMs)的模型,可有效应对子宫修复难题。

动物实验中,小鼠严重受损子宫几乎完全修复,小鼠实现正常妊娠、胎儿发育和活产。

相关研究成果以“Reconstructable Uterus-Derived Materials for Uterus Recovery toward Efficient Live Births”为题,发表在Advanced Materials(影响因子30.86)。

内膜损伤导致的不孕缺乏高效治疗策略

三胎政策放开后,“想生而生不出”是不少家庭正在遭遇的生育困境,“不孕不育”成为他们的隐痛。中国工程院院士、知名生殖医学专家乔杰,2021年在《柳叶刀》在线发表的一则报告中提到,我国的不孕率从2007年的12%上升至2010年的15%,2020年又上升到18%左右。

其中,由子宫内膜损伤引起的子宫性不孕越来越常见。

珠江医院妇产医学中心主任王沂峰表示,子宫内膜是一种高度再生的组织,在女性的生育阶段要经历多达约400个生长、脱落周期。而人工流产、刮宫、宫腔手术、感染等各种原因造成的子宫内膜损伤都可能引起内膜再生障碍,导致月经减少、闭经、反复流产及不孕。据报道,在不孕症患者中,内膜损伤的发生率约为五分之一。

▲ 妇产医学中心主任王沂峰

“目前对于子宫内膜受损没有很好的办法治疗,多是采用孕雌激素治疗,但是效果并不好。这使得很多女性丧失了生育能力。”王沂峰表示,传统的治疗办法无法有效治疗宫腔粘连,从而削弱了子宫修复能力,最终影响妊娠率。

新型材料有望高效应对子宫修复难题

鉴于此,王沂峰主任与其博士研究生易笑联合珠江医院转化医学中心再生医学研究所所长高毅教授、中国科学院理化技术研究所王树涛、南方医科大学基础医学院樊俊兵教授等开展了为期4年的合作研究,提出了一种可重构子宫衍生材料(RUMs)的模型,其具有可调的状态和形貌,可高效应对子宫修复难题。

据了解,珠江医院建立了全省首个新型生物纳米材料的类器官构建平台。本次研究的子宫衍生材料来源于平台再生细胞研究所提供的人类脐带干细胞和生物材料。

易笑表示,基于子宫的结构特点,该项研究制备了可注射RUMs凝胶和RUMs补片,其中RUMs凝胶可深入到达子宫内膜腔以有效阻止宫腔粘连并提高血管生成、内膜再生以及肌肉胶原重建能力。

▲ 妇产医学中心博士研究生易笑

与此同时,RUMs补片则粘附在子宫壁上加速伤口愈合和阻止伤口与腹部组织的粘连。不仅如此,RUMs还可以分泌一系列细胞因子来调节子宫微环境,从而促使伤口愈合和子宫修复。

据了解,为了研究RUM凝胶和补片协同修复子宫损伤的能力,研究团队构建了具有严重子宫损伤的大鼠模型。通过RUMs凝胶和补片的治疗,大鼠的子宫结构在第15天几乎得到了再生,有效帮助小鼠受孕和幼鼠出生恢复正常。

▲ 干细胞与再生医学研究所所长高毅

高毅教授表示,目前已经完成了小鼠的研究,未来将在猴子等大动物上验证,同时将该生物纳米材料送第三方的安全性评价。通过医学伦理和临床试验,未来RUMs凝胶和补片可作为一种产品给子宫内膜受损的患者局部应用。专家预计,此项产品3-4年后可应用于临床。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1708693, encodeId=b0ed1e08693d1, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Sun May 15 19:05:04 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237376, encodeId=e844123e37607, content=哎 **合法化不得了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erFE1IgJcfnOGsibGrna95eBt7ELNXK85krdEJ0RAYjiaU11PyPj40c1BsktlfCfLH0n9jm99iahR06w/132, createdBy=05422454711, createdName=慧子, createdTime=Mon Aug 08 15:52:10 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196152, encodeId=42b4119615279, content=探索无止境, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Tue Feb 22 16:47:01 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355097, encodeId=c039135509ec6, content=<a href='/topic/show?id=b9e02036159' target=_blank style='color:#2F92EE;'>#不孕不育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20361, encryptionId=b9e02036159, topicName=不孕不育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398287, encodeId=fcc6139828ea5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195297, encodeId=7e9f119529e32, content=希望早日应用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Sun Feb 20 10:48:28 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1708693, encodeId=b0ed1e08693d1, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Sun May 15 19:05:04 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237376, encodeId=e844123e37607, content=哎 **合法化不得了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erFE1IgJcfnOGsibGrna95eBt7ELNXK85krdEJ0RAYjiaU11PyPj40c1BsktlfCfLH0n9jm99iahR06w/132, createdBy=05422454711, createdName=慧子, createdTime=Mon Aug 08 15:52:10 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196152, encodeId=42b4119615279, content=探索无止境, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Tue Feb 22 16:47:01 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355097, encodeId=c039135509ec6, content=<a href='/topic/show?id=b9e02036159' target=_blank style='color:#2F92EE;'>#不孕不育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20361, encryptionId=b9e02036159, topicName=不孕不育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398287, encodeId=fcc6139828ea5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195297, encodeId=7e9f119529e32, content=希望早日应用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Sun Feb 20 10:48:28 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-08-08 慧子

    哎 **合法化不得了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1708693, encodeId=b0ed1e08693d1, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Sun May 15 19:05:04 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237376, encodeId=e844123e37607, content=哎 **合法化不得了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erFE1IgJcfnOGsibGrna95eBt7ELNXK85krdEJ0RAYjiaU11PyPj40c1BsktlfCfLH0n9jm99iahR06w/132, createdBy=05422454711, createdName=慧子, createdTime=Mon Aug 08 15:52:10 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196152, encodeId=42b4119615279, content=探索无止境, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Tue Feb 22 16:47:01 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355097, encodeId=c039135509ec6, content=<a href='/topic/show?id=b9e02036159' target=_blank style='color:#2F92EE;'>#不孕不育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20361, encryptionId=b9e02036159, topicName=不孕不育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398287, encodeId=fcc6139828ea5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195297, encodeId=7e9f119529e32, content=希望早日应用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Sun Feb 20 10:48:28 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-02-22 148a60abm39暂无昵称

    探索无止境

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1708693, encodeId=b0ed1e08693d1, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Sun May 15 19:05:04 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237376, encodeId=e844123e37607, content=哎 **合法化不得了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erFE1IgJcfnOGsibGrna95eBt7ELNXK85krdEJ0RAYjiaU11PyPj40c1BsktlfCfLH0n9jm99iahR06w/132, createdBy=05422454711, createdName=慧子, createdTime=Mon Aug 08 15:52:10 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196152, encodeId=42b4119615279, content=探索无止境, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Tue Feb 22 16:47:01 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355097, encodeId=c039135509ec6, content=<a href='/topic/show?id=b9e02036159' target=_blank style='color:#2F92EE;'>#不孕不育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20361, encryptionId=b9e02036159, topicName=不孕不育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398287, encodeId=fcc6139828ea5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195297, encodeId=7e9f119529e32, content=希望早日应用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Sun Feb 20 10:48:28 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1708693, encodeId=b0ed1e08693d1, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Sun May 15 19:05:04 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237376, encodeId=e844123e37607, content=哎 **合法化不得了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erFE1IgJcfnOGsibGrna95eBt7ELNXK85krdEJ0RAYjiaU11PyPj40c1BsktlfCfLH0n9jm99iahR06w/132, createdBy=05422454711, createdName=慧子, createdTime=Mon Aug 08 15:52:10 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196152, encodeId=42b4119615279, content=探索无止境, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Tue Feb 22 16:47:01 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355097, encodeId=c039135509ec6, content=<a href='/topic/show?id=b9e02036159' target=_blank style='color:#2F92EE;'>#不孕不育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20361, encryptionId=b9e02036159, topicName=不孕不育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398287, encodeId=fcc6139828ea5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195297, encodeId=7e9f119529e32, content=希望早日应用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Sun Feb 20 10:48:28 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1708693, encodeId=b0ed1e08693d1, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Sun May 15 19:05:04 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237376, encodeId=e844123e37607, content=哎 **合法化不得了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erFE1IgJcfnOGsibGrna95eBt7ELNXK85krdEJ0RAYjiaU11PyPj40c1BsktlfCfLH0n9jm99iahR06w/132, createdBy=05422454711, createdName=慧子, createdTime=Mon Aug 08 15:52:10 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196152, encodeId=42b4119615279, content=探索无止境, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Tue Feb 22 16:47:01 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355097, encodeId=c039135509ec6, content=<a href='/topic/show?id=b9e02036159' target=_blank style='color:#2F92EE;'>#不孕不育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20361, encryptionId=b9e02036159, topicName=不孕不育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398287, encodeId=fcc6139828ea5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sun Feb 20 11:05:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195297, encodeId=7e9f119529e32, content=希望早日应用于临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Sun Feb 20 10:48:28 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-02-20 ms8000002131411968

    希望早日应用于临床

    0

相关资讯

女性不孕不育与自身抗体(综述摘译)

孕不育患者中,约10%的病因不明,在这些病例中自身免疫性疾病(如:系统性红斑狼疮、抗磷脂综合征等)占有一定比例。

不孕不育增多,精子质量暴跌,现代男性如何夹缝中求生存?

5月11日,国家统计局发布第七次全国人口普查主要数据。此次普查数据显示,中国总人口为14亿1178万人。2020年我国出生人口为1200万人,创历史新低,较上年的1465万大幅下降了18%。

Aging Cell:不完全的脯氨酸分解促使精子过早衰老 

不孕症被定义为一对夫妇在无保护性行为后一年内无法受孕。据估计,在美国有12-13%的夫妇与不孕症作斗争。

13年随访数据,男性打呼噜不育风险增加1.2倍

不孕不育通常被定义为人类、动物或植物无法透过有性生殖繁衍后代。以往报告显示,在高收入国家,12个月内男性不育患病率在3.5%到16.7%,低收入国家在6.9%到9.3%,总体中位患病率约为9%。

Hum Reprod Update:辅助生育技术(ART) 在中低收入国家的应用情况

不孕症仍然是一个全球健康问题,在全世界范围内仍未得到充分解决。

Nature Communications:父母健康子代也会不育?科学家发现新型遗传机制或能解答不育未解之谜

此次研究是新型遗传机制的重大突破,对于未来研究方向的转变及男性不育症的临床治疗都具有重大借鉴意义。随着科学家在男性不育基因突变层面的深入研究,让我们期待基因疗法应用于不育症治疗的那一天。